Page results
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
File results
-
FOI/2022/0652 - UCLH palliative care policy
-
FOI/2022/0656 - Reinforced autoclaved aerated concrete (RAAC)
-
FOI/2022/0660 - Prostate cancer
-
FOI/2022/0663 - Migraine treatment
-
FOI/2022/0665 - Formal patient/ family complaints
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0646 - Endoscopic Retrogade Cholangiopancreatography
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)